In a report released today, Steven Halper from Cantor Fitzgerald reiterated a Hold rating on Hms Holdings Corp (HMSY), with a price target of $34. The company’s shares opened today at $33.
Halper noted:
“. We reiterate our Neutral rating on HMSY shares and increase our 12-month price target to $34 from $31. This morning, HMSY reported 4Q18 results. Revenue was roughly inline with our estimates and FactSet consensus, while adjusted EPS were ahead of expectations. Adjusted EPS benefited by about $0.17 in discrete tax benefits. The company also provided 2019 guidance, with revenue below our expectation and adjusted EBITDA above our prior estimate. Although margin expansion guidance was not provided for 2019, the company appears to be executing on improving profitability through solid cost management and investments in automation.”
According to TipRanks.com, Halper is a top 100 analyst with an average return of 20.4% and a 66.0% success rate. Halper covers the Services sector, focusing on stocks such as WellCare Health Plans, Tivity Health Inc, and Evolent Health.
Hms Holdings Corp has an analyst consensus of Moderate Buy, with a price target consensus of $41.
See today’s analyst top recommended stocks >>
Hms Holdings Corp’s market cap is currently $2.62B and has a P/E ratio of 56.99. The company has a Price to Book ratio of 4.02.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HMS Holdings Corp. engages in the provision of cost containment solutions in the healthcare marketplace. The firm operates through its wholly owned subsidiaries, Health Management Systems, Inc. HealthDataInsights, Inc., HMS Care Analytics, Inc., IntegriGuard, LLC, and Reimbursement Services Group Inc..
